ArticleInternational journal of hematology2025

Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post‑marketing surveillance in Japan.

Jun-Ichi Nishimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.